The role of positive information provision in open‐label placebo

Final Results of a Randomized, Phase III Study of Rituximab With or Without Idelalisib Followed by Open-Label Idelalisib in Patients With Relapsed Chronic Lymphocytic Leukemia

Trial of SAGE-217 in Patients with Major Depressive Disorder

What is an Open-Label Clinical Trial?

Question 2 36 pts Open-label placebo works as well as

A Phase II, Randomized, Double-blind, Placebo-controlled Multicenter Trial of Endostar in Patients With Metastatic Melanoma: Molecular Therapy

Placebo and nocebo effects: from observation to harnessing and clinical application

Expected Open-Label Placebo Effects

Active placebo control group controls for the normal placebo benefits

Taking a placebo improves adherence to treatment for opioid use disorder, study finds